Red Door Wealth Management LLC Purchases 1,180 Shares of UnitedHealth Group Incorporated $UNH

Red Door Wealth Management LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 22,560 shares of the healthcare conglomerate’s stock after acquiring an additional 1,180 shares during the period. Red Door Wealth Management LLC’s holdings in UnitedHealth Group were worth $6,104,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Patriot Financial Group Insurance Agency LLC raised its holdings in UnitedHealth Group by 31.5% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 5,318 shares of the healthcare conglomerate’s stock worth $1,439,000 after purchasing an additional 1,275 shares in the last quarter. MeadowBrook Investment Advisors LLC boosted its holdings in shares of UnitedHealth Group by 9.0% during the 1st quarter. MeadowBrook Investment Advisors LLC now owns 4,429 shares of the healthcare conglomerate’s stock valued at $1,198,000 after buying an additional 367 shares in the last quarter. Skylands Capital LLC increased its stake in shares of UnitedHealth Group by 20.9% in the 1st quarter. Skylands Capital LLC now owns 9,695 shares of the healthcare conglomerate’s stock worth $2,623,000 after acquiring an additional 1,675 shares in the last quarter. Janney Montgomery Scott LLC boosted its stake in UnitedHealth Group by 22.8% during the first quarter. Janney Montgomery Scott LLC now owns 264,200 shares of the healthcare conglomerate’s stock worth $71,490,000 after acquiring an additional 49,092 shares in the last quarter. Finally, Diamant Asset Management Inc. grew its holdings in UnitedHealth Group by 26,148.5% in the first quarter. Diamant Asset Management Inc. now owns 569,592 shares of the healthcare conglomerate’s stock worth $154,126,000 after purchasing an additional 567,422 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 0.1%

Shares of UnitedHealth Group stock opened at $427.47 on Monday. The company has a market cap of $388.21 billion, a price-to-earnings ratio of 32.29, a price-to-earnings-growth ratio of 1.72 and a beta of 0.64. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.69. The company’s 50 day moving average is $383.92 and its 200 day moving average is $332.50. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $427.93.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The company’s revenue for the quarter was up 2.0% on a year-over-year basis. During the same period last year, the business posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 18.32 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a dividend of $2.32 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Monday, June 15th. UnitedHealth Group’s dividend payout ratio is currently 70.09%.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.28% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. Royal Bank Of Canada boosted their price target on UnitedHealth Group from $361.00 to $400.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. HC Wainwright set a $492.00 price objective on UnitedHealth Group in a research note on Wednesday, May 27th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target for the company in a report on Tuesday, April 7th. Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target on the stock in a research note on Wednesday, April 22nd. Finally, Wells Fargo & Company lifted their target price on shares of UnitedHealth Group from $370.00 to $397.00 and gave the stock an “overweight” rating in a report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $410.79.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Wall Street sentiment remains constructive, with multiple firms reiterating bullish ratings and several recent price-target increases, including a new $475 target from BofA Securities. That suggests analysts see room for further upside as margins and Optum Health improve. What to Expect From UnitedHealth Group’s Q2 2026 Earnings Report
• Positive Sentiment: Investors appear to be rotating into healthcare as a defensive play while technology stocks weaken, which is supporting demand for UNH shares. Social-media chatter also points to continued interest in the company’s recovery narrative and its resilient insurance and medical-services business. UnitedHealth Group Stock (UNH) Opinions on Market Rotation and Analyst Upgrades
• Positive Sentiment: Market coverage ahead of the Q2 2026 report says analysts expect double-digit EPS growth, reinforcing the idea that earnings could justify the stock’s recent move higher. What to Expect From UnitedHealth Group’s Q2 2026 Earnings Report
• Neutral Sentiment: Recent articles also frame UNH as a long-term value and healthcare watchlist name, which supports investor interest but does not by itself add a fresh catalyst.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.